Condition
Cerebrotendinous Xanthomatosis
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Unknown2
Withdrawn1
Enrolling By Invitation1
Clinical Trials (4)
Showing 4 of 4 trials
NCT05368038Enrolling By Invitation
ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program
NCT03584893UnknownPrimary
The Prevalence of CTX Disorder in Juvenile Cataract Cases in Turkey
NCT00018694Not ApplicableWithdrawnPrimary
Cholestanol in Humans
NCT00004346Phase 2UnknownPrimary
Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis
Showing all 4 trials